Emage Medical

What Emage Medical does

Emage Medical is a Charlotte, North Carolina-based medical aesthetic device company founded in 2001 by Lonnie Wallace. The company designs, distributes, and finances a portfolio of FDA-cleared hardware systems — centered on the Image Pro® skin imaging line (Sunlite, HYBRID, Opera 3D, Halo) and treatment devices including CytoPen® microneedling pens, Cyto-RF® RF microneedling, CytoPeel® hydradermabrasion, StemFacial® microneedling with cytokine growth factors, plus CytoSerum® and HairPRO for hair restoration. Image Pro® systems use proprietary algorithms trained on nearly two decades of clinical data (claimed 98% accuracy vs. dermatologist visual observation), AI-powered facial recognition for client matching across appointments, a dual light source architecture combining zeon flash lamps and LEDs, and Violeds self-sanitizing technology that achieves 99.9% sterilization in 20 seconds.

The company sells exclusively to licensed aesthetic and medical professionals — medspas, dermatologists, plastic surgeons, and licensed estheticians — across the United States, verified through professional credential checks. Revenue is generated through a hybrid model: one-time hardware purchases alongside flexible monthly financing starting at $45/month (encompassing consumer-style payments for capital equipment), plus recurring consumables revenue from CytoSolutions skincare formulas. Go-to-market combines inside phone-based sales, a free 10-minute virtual product tour as the primary discovery mechanism, content marketing and SEO, active social presence across five platforms, trade show and conference participation (with VP Sales Sally Bevans having spoken at over 20 events), and a provider directory that drives peer referral traffic. Pricing is positioned as the most affordable advanced skin imaging in the industry, with no annual licensing fees and free lifetime software upgrades — contrasting with competitors charging $1,400+/year post-warranty.

Emage operates with approximately 10 employees and reported revenue exceeding $2.7 million annually as of 2023, up from $80,000 in 2011. The company is currently undergoing an ownership transition, with CEO Sally Bevans acquiring Emage from founder Wallace and articulating plans to expand the platform beyond aesthetics into anti-aging and regenerative medicine offerings.

Name

Emage Medical

Legal name

Emage Medical LLC

Website

https://emagemedical.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

Emage Medical is a Charlotte, NC-based designer and distributor of FDA-cleared aesthetic devices — including AI-powered skin imaging systems, microneedling pens, RF microneedling, and hydradermabrasion equipment — sold exclusively to licensed medspas, dermatologists, plastic surgeons, and estheticians across the United States, with revenue from hardware sales, financing, and skincare consumables.

Ownership category

akta.pro rank

Headquarters

HQ city

Charlotte

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Aesthetic Device Sales (Outright Purchase): Sale of aesthetic medical devices including skin imaging systems, microneedling pens, RF microneedling machines, hydradermabrasion systems, and hair restoration equipment. Devices are sold directly to licensed aesthetic and medical professionals. One-time hardware purchase option available alongside financing.
2. Equipment Financing/Leasing: Flexible financing programs with monthly payments starting as low as $45/month, enabling aesthetic practices to lease equipment rather than purchase outright. Financing covers the full product lineup from skin imaging to microneedling systems with flexible terms and no prepayment penalties.
3. CytoSolutions Skincare Formulas: Sale of proprietary skin-boosting formulas (growth factors, restorative acids, organic compounds, vitamins) that pair with CytoPeel and microneedling treatments. Sold as add-on consumables to device customers.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Emage Medical designs, manufactures, and sells FDA-cleared aesthetic medical devices to licensed professionals across the United States. The product line includes AI-powered Image Pro skin imaging systems (Sunlite, HYBRID, Opera 3D, Halo), CytoPen microneedling pens, Cyto-RF radiofrequency microneedling, StemFacial microneedling, CytoPeel hydradermabrasion, and CytoSerum / ImagePro HairPRO hair restoration systems. Equipment is sold outright or financed through monthly lease programs starting as low as $45/month, bundled with unlimited 1:1 training and a 3-year warranty.

Product overview

Emage Medical® is a medical aesthetic device company offering a comprehensive portfolio of advanced aesthetic technologies designed for medspas, dermatologists, and cosmetic professionals. The product lineup centers on the Image Pro® skin imaging systems (Sunlite, HYBRID, Opera 3D, and Halo) which provide high-resolution 3D skin analysis using AI-powered facial recognition and multiple light wavelengths. This imaging technology integrates with and supports upselling of treatment devices including the CytoPen® microneedling pens (NG and S2 models), the Cyto-RF® RF microneedling system, and the StemFacial® microneedling system with cytokine growth factors. The CytoPeel® dual microdermabrasion/hydradermabrasion system works in conjunction with CytoSolutions skin-boosting formulas. For hair restoration, the company offers CytoSerum® and ImagePro® HairPRO. All products are FDA-cleared where applicable and are supported by comprehensive training, marketing assistance, and flexible financing programs.

Differentiator

Problem solved

Functional benefit

Brands

• Image Pro: Line of skin imaging systems including Sunlite, HYBRID, Opera 3D, and Halo models. Uses proprietary algorithms drawing on nearly two decades of global clinical data.
• CytoPen
• Cyto-RF
• CytoPeel
• StemFacial
• CytoSolutions
• CytoSerum
• HairPRO

Products and services

• Image Pro Skin Imaging Systems AI-powered 2D and 3D skin imaging systems for medspas and dermatology practices. Models include Image Pro Sunlite (3D spectral imaging with dual light sources), HYBRID (with AI facial recognition and Violeds self-sanitization), Opera 3D (treatment progress monitoring), and Halo (four-spectrum analysis with retractable hood).
• CytoPen Microneedling Pens FDA-cleared battery-powered microneedling pens available in NG (lightweight, seven speed settings, 16-needle cartridge) and S2 (aluminum housing, 12/36-needle scalloped cartridges plus Nano tip) models for collagen induction therapy in aesthetic practices.
• Cyto-RF RF Microneedling System FDA-cleared RF microneedling system that fuses fractional non-ablative radiofrequency with gold-plated microneedles for deeper collagen stimulation and firmer, tighter skin. Targeted at aesthetic and medical practices seeking advanced skin rejuvenation.
• StemFacial Microneedling System Advanced proprietary microneedling system utilizing cytokine growth factors combined with the CytoPen device to provide fast results and lasting skin rejuvenation benefits. Marketed with a 10x ROI claim for providers.
• CytoPeel Hydradermabrasion Device All-in-one microdermabrasion and hydradermabrasion device featuring a diamond tip, cooling handpiece, micro-spray mist, RF heating, ultrasound, and quad-polar collagen induction for smoother, tighter, and more radiant skin.
• CytoSolutions Skincare Formulas Skin-boosting formulas combining growth factors, restorative acids, organic compounds, and critical vitamins designed to reduce recovery time and maximize results when used with CytoPeel or microneedling treatments. Sold as add-on consumables to device customers.
• CytoSerum Hair Restoration Hair restoration system promoting natural hair growth through stem cell activation, amino acids, and new blood vessel formation, with visible results typically within three months.
• ImagePro HairPRO Skin imaging system designed for hair restoration consultations, helping providers analyze scalp conditions and recommend appropriate hair restoration treatments.

Quantifiable outcome

• 98% accuracy in identifying skin conditions compared to visual observation by dermatologists
• +4 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Venus Concept: Aesthetic device company selling RF, microneedling, and laser hair restoration systems (e.g., NeoGraft) to medspas and aesthetic practices. Comparable device portfolio, customer segment, and hair restoration overlap with CytoSerum® and HairPRO.
• Alma Lasers: Global aesthetic device manufacturer offering lasers, RF, and body contouring platforms. Overlapping medspa/dermatology customer base and energy-based device category with Emage.
• Cutera: Public aesthetic device company selling laser, RF, and microneedling platforms to dermatology and medspa customers. Directly comparable customer segment and overlapping RF/microneedling product category with Emage.
• Solta Medical (Bausch Health): Established aesthetic device brand (Thermage, Fraxel, Clear+Brilliant) within Bausch Health. Comparable target customer and energy-based device category, though at much larger scale than Emage.
• Sciton: Premium U.S. manufacturer of laser and light-based aesthetic platforms sold to dermatology and plastic surgery practices. Comparable physician customer base and aesthetic device category.
• InMode: Public aesthetic device company with a strong RF microneedling franchise (Morpheus8) plus body contouring and laser platforms. Closely comparable in RF microneedling and medspa channel.
• Cynosure (Hologic): Large aesthetic device portfolio under Hologic covering lasers, RF, and body contouring sold to medspas and plastic surgeons. Overlaps with Emage's RF microneedling (Cyto-RF®) and broader medspa customer base.

Direct peers

• Cartessa Aesthetics: U.S. aesthetic device distributor/manufacturer marketing devices such as SkinStylus Microneedling and VirtueRF directly to medspas and physicians. Highly comparable go-to-market motion, customer segment, and product overlap with Emage's CytoPen® and Cyto-RF® lines.
• Canfield Scientific: Maker of the VISIA skin imaging system, the dominant clinical aesthetic imaging platform in dermatology and medspas. Directly competes with Emage's Image Pro® line on skin analysis features, accuracy claims, and physician customers.
• FotoFinder Systems: German manufacturer of advanced skin and hair imaging systems (e.g., FotoFinder ATBM, Trichoscale). Competes with Emage's Image Pro® and HairPRO offerings, particularly in dermatology and trichology practices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@emagemedical
• Facebookfacebook.com/EmageMedicalLLC
• LinkedInlinkedin.com/company/emagemedical
• Instagraminstagram.com/emage.medical
• TikToktiktok.com/@emagemedical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emage Medical